ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1041
-0,01%
Bitcoin
71.147,30
-0,42%
Brent Oil
82,345
-1,42%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Proteon Therapeutics Inc (PRTO)

  7. Proteon Therapeutics Inc (PRTO) Notícias

PRTO

Proteon Therapeutics (PRTO)

Proteon Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTO
DataHoraFonteTítuloCódigoCompanhia
21/01/202019:16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRTOProteon Therapeutics Inc
17/01/202018:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
16/01/202010:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTOProteon Therapeutics Inc
15/01/202008:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRTOProteon Therapeutics Inc
13/01/202020:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRTOProteon Therapeutics Inc
13/01/202020:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
10/01/202019:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
09/01/202015:43GlobeNewswire Inc.ArTara Therapeutics Completes Merger Transaction with Proteon TherapeuticsNASDAQ:PRTOProteon Therapeutics Inc
31/12/201918:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201918:06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201908:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRTOProteon Therapeutics Inc
19/12/201918:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PRTOProteon Therapeutics Inc
18/12/201919:46Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
03/12/201919:45PR Newswire (US)Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T...NASDAQ:PRTOProteon Therapeutics Inc
22/11/201912:37PR Newswire (US)Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an...NASDAQ:PRTOProteon Therapeutics Inc
21/11/201919:33PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.NASDAQ:PRTOProteon Therapeutics Inc
07/11/201908:09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PRTOProteon Therapeutics Inc
31/10/201918:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRTOProteon Therapeutics Inc
23/09/201917:20GlobeNewswire Inc.Proteon Therapeutics and ArTara Therapeutics Agree to CombineNASDAQ:PRTOProteon Therapeutics Inc
07/08/201909:00GlobeNewswire Inc.Proteon Therapeutics Announces Second Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
08/05/201909:00GlobeNewswire Inc.Proteon Therapeutics Announces First Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
15/04/201917:30GlobeNewswire Inc.Proteon Therapeutics Announces Review of Potential Strategic TransactionsNASDAQ:PRTOProteon Therapeutics Inc
12/04/201909:11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PRTOProteon Therapeutics Inc
28/03/201909:00GlobeNewswire Inc.Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteri...NASDAQ:PRTOProteon Therapeutics Inc
14/03/201918:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201909:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201909:00GlobeNewswire Inc.Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
04/03/201918:30GlobeNewswire Inc.Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11thNASDAQ:PRTOProteon Therapeutics Inc
24/01/201911:00GlobeNewswire Inc.Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase i...NASDAQ:PRTOProteon Therapeutics Inc
18/12/201811:41Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PRTOProteon Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRTO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
CASH3
Meliuz S.A ON
BOV
INBR32
Inter &
BOV
GOLL4
GOL PN
BOV
LUPA3
LUPATECH ON
BOV
LWSA3
LOCAWEB ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados